Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
| 01/31/2020 | 10/31/2019 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.12% | -2.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.51% | -3.01% | |||
| Operating Income | 3.51% | 3.01% | |||
| Income Before Tax | 0.05% | -2.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.05% | -2.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.05% | -2.24% | |||
| EBIT | 3.51% | 3.01% | |||
| EBITDA | 3.66% | 3.03% | |||
| EPS Basic | 0.00% | -2.22% | |||
| Normalized Basic EPS | 0.00% | -1.77% | |||
| EPS Diluted | 0.00% | -2.22% | |||
| Normalized Diluted EPS | 0.00% | -1.77% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||